2016
DOI: 10.1016/j.ultras.2015.10.008
|View full text |Cite
|
Sign up to set email alerts
|

Sonodynamic action of hypocrellin B on methicillin-resistant Staphylococcus aureus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(29 citation statements)
references
References 28 publications
0
29
0
Order By: Relevance
“…[41] Especially, the surface-modified polymeric phenyboronic acid enabled targeted delivery of DOX-loaded titanium dioxide nanoparticles, by which the combined therapeutic effect was realized as demonstrated by the substantially inhibited tumor growth upon US irradiation (15 W cm −2 , 1.5 MHz, duty cycle: 20%). [42] In addition to the broadly explored antitumor use of nanosonosensitizer-enabled SDT in the aforementioned paradigms, it can also be adopted for treating pathogenic bacterial infection, [44][45][46][47] because it can overcome the barriers of traditional antibiotics such as multidrug resistant after continuous and repeated antibiotic administrations. As a proof-of-concept paradigm, a US-sensitive Pd@Pt-T790 nanosonosensitizer was constructed by linking sonosensitizers meso-tetra(4-carboxyphenyl) porphine (T790) with Pd@Pt nanoplates (Figure 4).…”
Section: Sonodynamic Therapymentioning
confidence: 99%
See 1 more Smart Citation
“…[41] Especially, the surface-modified polymeric phenyboronic acid enabled targeted delivery of DOX-loaded titanium dioxide nanoparticles, by which the combined therapeutic effect was realized as demonstrated by the substantially inhibited tumor growth upon US irradiation (15 W cm −2 , 1.5 MHz, duty cycle: 20%). [42] In addition to the broadly explored antitumor use of nanosonosensitizer-enabled SDT in the aforementioned paradigms, it can also be adopted for treating pathogenic bacterial infection, [44][45][46][47] because it can overcome the barriers of traditional antibiotics such as multidrug resistant after continuous and repeated antibiotic administrations. As a proof-of-concept paradigm, a US-sensitive Pd@Pt-T790 nanosonosensitizer was constructed by linking sonosensitizers meso-tetra(4-carboxyphenyl) porphine (T790) with Pd@Pt nanoplates (Figure 4).…”
Section: Sonodynamic Therapymentioning
confidence: 99%
“…In addition to the broadly explored antitumor use of nanosonosensitizer‐enabled SDT in the aforementioned paradigms, it can also be adopted for treating pathogenic bacterial infection, [ 44–47 ] because it can overcome the barriers of traditional antibiotics such as multidrug resistant after continuous and repeated antibiotic administrations. As a proof‐of‐concept paradigm, a US‐sensitive Pd@Pt‐T790 nanosonosensitizer was constructed by linking sonosensitizers meso‐tetra(4‐carboxyphenyl)porphine (T790) with Pd@Pt nanoplates ( Figure ).…”
Section: Sonodynamic Therapymentioning
confidence: 99%
“…After excluding non-eligible papers, 20 articles had eligibility to be considered for full-text reading. Of these 20 studies, 4 studies were further excluded and in the final stage of screening, 14 studies [11][12][13][14][15][16][17][18][19][20][21][22][23][24] were included in the current systematic review and meta-analysis. The main characteristics of the included studies are described in Table 1.…”
Section: Study Characteristicsmentioning
confidence: 99%
“…Most specimens in ND and D control groups showed disordered connective tissue and even supragingival plaque [15,16,11]. In our previous study, HMME-mediated SDT could effectively kill more than 95% of Staphylococcus aureus [14].…”
Section: Histological Analysismentioning
confidence: 99%
“…Recently, many studies have indicated satisfactory results with SDT in inhibiting bacteria such as methicillin-resistant staphylococcus aureus (MRSA) [15], bacillus cereus and escherichia coli [16]. Our previous study showed that HMME-mediated SDT could effectively inhibit the growth of staphylococcus aureus [14].…”
Section: Introductionmentioning
confidence: 99%